Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious...
Vous n'êtes pas connecté
A researcher in Purdue University’s College of Science, USA, is developing a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells. David Thompson leads a team developing the carrier system called LENN. He is a professor in the James Tarpo Jr. and Margaret Tarpo Department of [...]
Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious...
Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious...
The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most...
The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most...
Acepodia, a clinical─stage biotechnology company developing first─in─class cell therapies with its unique antibody─cell conjugation (ACC) and...
Acepodia, a clinical─stage biotechnology company developing first─in─class cell therapies with its unique antibody─cell conjugation (ACC) and...
Researchers from Monash University, led by Associate Professor Mikaël Martino from the university’s Australian Regenerative Medical Research...
Elevated sodium levels in tumors boost T-cell metabolic fitness and cytotoxicity, revealing potential avenues for improving cancer therapies.
Elevated sodium levels in tumors boost T-cell metabolic fitness and cytotoxicity, revealing potential avenues for improving cancer therapies.
In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the...